compound 8c [PMID: 28760529]   Click here for help

GtoPdb Ligand ID: 9671

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: 8c is a potent B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor with a favourable pharmacokinetic profile for drug development [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 102.73
Molecular weight 417.11
XLogP 2.95
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C1CCc2c(N1)ccc(c2)Nc1cc(OC2CCOCC2)c(cc1Cl)[N+](=O)[O-]
Isomeric SMILES O=C1CCc2c(N1)ccc(c2)Nc1cc(OC2CCOCC2)c(cc1Cl)[N+](=O)[O-]
InChI InChI=1S/C20H20ClN3O5/c21-15-10-18(24(26)27)19(29-14-5-7-28-8-6-14)11-17(15)22-13-2-3-16-12(9-13)1-4-20(25)23-16/h2-3,9-11,14,22H,1,4-8H2,(H,23,25)
InChI Key RRELDGDKULRRDM-UHFFFAOYSA-N
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
BCL6 transcription repressor Hs Inhibitor Binding 6.1 – 7.0 pIC50 - 1
pIC50 7.0 (IC50 1x10-7 M) [1]
Description: In a cell-free ELISA system measuring ability to inhibit BCL6 BTB domain-NCoR interaction.
pIC50 6.1 (IC50 7.2x10-7 M) [1]
Description: In a cell-based mammalian two-hybrid system assessing inhibition of protein-protein interaction between BCL6 BTB domain and BCoR.